Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q3 2024 ▲▼ | Q4 2024 ▲▼ | Change ▲▼ | Q3 2024 ▲▼ | Q4 2024 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Eli Lilly and Company(LLY) | 30,564 | 37,068 | +6,504 | $27.08M | $28.68M | 13.60% | +$1.61M |
| UnitedHealth Group Incorporated(UNH) | 35,490 | 35,202 | -288 | $20.75M | $17.88M | 8.48% | -$2.87M |
| AbbVie Inc.(ABBV) | 44,486 | 90,723 | +46,237 | $8.79M | $15.99M | 7.58% | +$7.20M |
| Boston Scientific Corporation(BSX) | 106,172 | 154,222 | +48,050 | $8.90M | $13.83M | 6.56% | +$4.93M |
| Thermo Fisher Scientific Inc.(TMO) | 22,012 | 24,896 | +2,884 | $13.62M | $12.92M | 6.13% | -$698.9K |
| Merck & Co., Inc.(MRK) | 154,699 | 105,727 | -48,972 | $17.57M | $10.40M | 4.93% | -$7.17M |
| Stryker Corporation(SYK) | 23,460 | 25,660 | +2,200 | $8.48M | $9.30M | 4.41% | +$820.4K |
| Neurocrine Biosciences, Inc.(NBIX) | 60,607 | 67,763 | +7,156 | $6.98M | $9.29M | 4.40% | +$2.30M |
| Alkermes plcSHS(ALKS) | 236,610 | 266,499 | +29,889 | $6.62M | $7.67M | 3.64% | +$1.05M |
| Vertex Pharmaceuticals Incorporated(VRTX) | 16,993 | 22,257 | +5,264 | $7.90M | $7.60M | 3.60% | -$307.5K |
| Cencora Inc | 36,544 | 32,553 | -3,991 | $8.23M | $7.31M | 3.47% | -$910.3K |
| Amgen Inc.(AMGN) | 28,965 | 27,414 | -1,551 | $9.33M | $7.11M | 3.37% | -$2.22M |
| Intra-Cellular Therapies Inc | 84,578 | 71,138 | -13,440 | $6.19M | $5.94M | 2.82% | -$250.0K |
| Edwards Lifesciences Corp | 36,505 | 68,296 | +31,791 | $2.41M | $5.07M | 2.40% | +$2.66M |
| Mirum Pharmaceuticals, Inc.(MIRM) | 138,321 | 116,692 | -21,629 | $5.39M | $4.81M | 2.28% | -$589.1K |
| DexCom, Inc.(DXCM) | 53,757 | 60,057 | +6,300 | $3.60M | $4.68M | 2.22% | +$1.08M |
| Harmony Biosciences Holdings, Inc.(HRMY) | 151,875 | 120,501 | -31,374 | $6.08M | $4.10M | 1.95% | -$1.97M |
| Cardinal Health, Inc.(CAH) | 27,500 | 30,680 | +3,180 | $3.04M | $3.62M | 1.72% | +$578.5K |
| Newamsterdam Pharma Company ORDINARY SHARES | 138,983 | 138,983 | 0 | $2.31M | $3.56M | 1.69% | +$1.25M |
| Arcellx Inc COMMON STOCK | 40,230 | 42,071 | +1,841 | $3.36M | $3.30M | 1.56% | -$63.3K |
| UFP Technologies, Inc.(UFPT) | 18,048 | 23,159 | +5,111 | $5.72M | $3.17M | 1.50% | -$2.55M |
| Amicus Therapeutics Inc COM | 275,472 | 326,840 | +51,368 | $2.94M | $3.08M | 1.46% | +$133.5K |
| BridgeBio Pharma, Inc.(BBIO) | 53,432 | 103,032 | +49,600 | $1.36M | $2.81M | 1.34% | +$1.45M |
| Revolution Medicines, Inc.(RVMD) | 0 | 62,161 | +62,161 | $0 | $2.68M | 1.27% | +$2.68M |
| Merus N V | 50,687 | 62,521 | +11,834 | $2.53M | $2.62M | 1.24% | +$86.7K |
| Janux Therapeutics, Inc.(JANX) | 0 | 39,573 | +39,573 | $0 | $2.08M | 0.99% | +$2.08M |
| BeOne Medicines AGADR(ONC) | 0 | 10,900 | +10,900 | $0 | $2.00M | 0.95% | +$2.00M |
| Krystal Biotech, Inc.(KRYS) | 9,202 | 9,202 | 0 | $1.68M | $1.47M | 0.70% | -$204.6K |
| Mereo BioPharma Group plcADS(MREO) | 200,000 | 390,000 | +190,000 | $822.0K | $1.37M | 0.65% | +$550.8K |
| Summit Therapeutics Inc.(SMMT) | 86,013 | 101,177 | +15,164 | $1.88M | $1.31M | 0.62% | -$569.0K |
| Corbus Pharmaceuticals Holdings, Inc.(CRBP) | 69,573 | 98,304 | +28,731 | $1.44M | $1.19M | 0.56% | -$247.8K |
| Autolus Therapeutics plcADS(AUTL) | 442,423 | 479,644 | +37,221 | $1.61M | $1.06M | 0.50% | -$546.0K |
| Soleno Therapeutics Inc | 26,390 | 30,940 | +4,550 | $1.33M | $984.8K | 0.47% | -$347.6K |
| Mersana Therapeutics Inc | 538,621 | 538,621 | 0 | $1.02M | $764.8K | 0.36% | -$253.2K |
| Pharvaris N V COM | 34,328 | 34,328 | 0 | $635.8K | $652.9K | 0.31% | +$17.2K |
| Cabaletta Bio, Inc.(CABA) | 168,522 | 247,454 | +78,932 | $795.4K | $554.3K | 0.26% | -$241.1K |
| Immunocore Holdings plcADS(IMCR) | 54,060 | 0 | -54,060 | $1.68M | $0 | — | -$1.68M |
| Ionis Pharmaceuticals, Inc.(IONS) | 82,691 | 0 | -82,691 | $3.31M | $0 | — | -$3.31M |
| Regeneron Pharmaceuticals, Inc.(REGN) | 7,028 | 0 | -7,028 | $7.39M | $0 | — | -$7.39M |